Metathesis between [(Me3Si)2CH)(C6H4-2-OMe)P]K and SmI2(THF)2 in THF yields [([Me3Si]2CH)(C6H4-2-OMe)P)2Sm(DME)(THF)] (1), after recrystallization. A similar reaction between [(Me3Si)2CH)(C6H3-2-OMe-3-Me)P]K and SmI2(THF)2 yields [([Me3Si]2CH)(C6H3-2-OMe-3-Me)P)2Sm(DME)].Et2O (2), while reaction between [(Me3Si)2CH)(C6H4-2-CH2NMe2)P]K and either SmI2(THF)2 or YbI2 yields the five-coordinate complex [([Me3Si]2CH)(C6H4-2-CH2NMe2)P)2Sm(THF)] (3) or the solvent-free complex [([Me3Si]2CH)(C6H4-2-CH2NMe2)P)2Yb] (4), respectively. X-ray crystallography shows that complex 2 adopts a distorted cis octahedral geometry, while complex 1 adopts a distorted pentagonal bipyramidal geometry (1, triclinic, P1, a = 11.0625(9) A, b = 15.924(6) A, c = 17.2104(14) A, alpha = 72.327(2) degrees, beta = 83.934(2) degrees, gamma = 79.556(2) degrees, Z = 2; 2, monoclinic, P2(1), a = 13.176(4) A, b = 13.080(4) A, c = 14.546(4) A, beta = 95.363(6) degrees, Z = 2). Complex 3 crystallizes as monomers with a square pyramidal geometry at Sm and exhibits short contacts between Sm and the ipso-carbon atoms of the ligands (3, monoclinic, C2/c, a = 14.9880(17) A, b = 13.0528(15) A, c = 24.330(3) A, beta = 104.507(2) degrees, Z = 4). Whereas preliminary X-ray crystallographic data for 4 indicate a monomeric structure in the solid state, variable-temperature 1H, 13C(1H), 31P(1H), and 171Yb NMR spectroscopies suggest that 4 undergoes an unusual dynamic process in solution, which is ascribed to a monomer-dimer equilibrium in which exchange of the bridging and terminal phosphide groups may be frozen out at low temperature.
No takes yet. Share an insight, caveat, or question.
Izod et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: